This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Atems Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Byung Hyune Choi: Innovator in Cartilage Regeneration
Introduction
Byung Hyune Choi is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of cartilage regeneration through his innovative research and development.
Latest Patents
Choi holds a patent for a composition aimed at cartilage regeneration. The patent, titled "Composition for cartilage regeneration and preparing thereof," describes a cartilage regenerating composition that includes fetal cartilage tissue-derived cells and an extracellular matrix derived from fetal cartilage tissue. This invention allows for the production of a three-dimensional tissue suitable for use as cartilage without the need for a scaffold. The composition can be administered in gel form, making it easily transplantable regardless of the size and shape of the cartilage defect. It exhibits high application and adhesion, a strong binding ability to host tissue, and a phenotype of mature cartilage tissue, resulting in an excellent cartilage regeneration effect.
Career Highlights
Choi's career is marked by his dedication to advancing medical technologies, particularly in the area of tissue engineering. His work has the potential to significantly improve treatment options for patients with cartilage damage.
Collaborations
Choi collaborates with talented individuals in his field, including Byoung-Hyun Min and So Ra Park. Their combined expertise contributes to the innovative research and development efforts at Atems Co., Ltd.
Conclusion
Byung Hyune Choi's contributions to cartilage regeneration highlight the importance of innovation in medical science. His work not only advances the field but also offers hope for improved treatments for cartilage-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile